BioXcel Therapeutics Inc [NASDAQ: BTAI] traded at a high on Wednesday, posting a 7.73 gain after which it closed the day’ session at $2.37.
The results of the trading session contributed to over 4178194 shares changing hands. Over the past one week, the price volatility of BioXcel Therapeutics Inc stands at 19.31% while the volatility over the past one month is 29.52%.
The market cap for BTAI stock reached $7.80 million, with 3.29 million shares outstanding and 2.74 million shares in the current float. Compared to the average trading volume of 4.70M shares, BTAI reached a trading volume of 4178194 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about BioXcel Therapeutics Inc [BTAI]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BTAI shares is $49.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BTAI stock is a recommendation set at 1.75. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for BioXcel Therapeutics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on February 21, 2024. While these analysts kept the previous recommendation, Mizuho dropped their target price from $40 to $4. The new note on the price target was released on August 15, 2023, representing the official price target for BioXcel Therapeutics Inc stock. On March 10, 2023, analysts increased their price target for BTAI shares from 20 to 22.
The Average True Range (ATR) for BioXcel Therapeutics Inc is set at 0.69, with the Price to Sales ratio for BTAI stock in the period of the last 12 months amounting to 3.42.
How has BTAI stock performed recently?
BioXcel Therapeutics Inc [BTAI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.47. With this latest performance, BTAI shares gained by 4.41% in over the last four-week period, additionally sinking by -76.86% over the last 6 months – not to mention a drop of -94.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BTAI stock in for the last two-week period is set at 43.98, with the RSI for the last a single of trading hit 46.12, and the three-weeks RSI is set at 42.48 for BioXcel Therapeutics Inc [BTAI]. The present Moving Average for the last 50 days of trading for this stock 3.87, while it was recorded at 2.24 for the last single week of trading, and 10.23 for the last 200 days.
BioXcel Therapeutics Inc [BTAI]: Deeper insight into the fundamentals
BioXcel Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.81 and a Current Ratio set at 1.87.
Earnings analysis for BioXcel Therapeutics Inc [BTAI]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BTAI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for BioXcel Therapeutics Inc go to 50.34%.
Insider trade positions for BioXcel Therapeutics Inc [BTAI]
There are presently around $14.06%, or 16.62%% of BTAI stock, in the hands of institutional investors. The top three institutional holders of BTAI stocks are: VANGUARD GROUP INC with ownership of 0.97 million shares, which is approximately 3.1438%. BLACKROCK INC., holding 0.44 million shares of the stock with an approximate value of $$0.56 million in BTAI stocks shares; and BLACKROCK INC., currently with $$0.34 million in BTAI stock with ownership which is approximately 0.8641%.
